# Omega 3 Supplementation in Cystic Fibrosis Patients

> **NCT00959010** · PHASE3 · COMPLETED · sponsor: **Queen Fabiola Children's University Hospital** · enrollment: 15 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 triglycerides
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00959010
- **Lead sponsor:** Queen Fabiola Children's University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-06
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959010, "Omega 3 Supplementation in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00959010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*